Risk factor
Very poor trading liquidity
Profitability factor
Very strong margins and returns
About
MeVis Medical Solutions AG, a German enterprise established in Bremen in 1992 and operating as a subsidiary of Varex Imaging Deutschland AG, specializes in developing and marketing sophisticated software solutions. These solutions are designed for the in-depth analysis and evaluation of medical imaging data. The company serves a diverse client base across the United States and Europe, including manufacturers of medical devices, providers of healthcare IT platforms, and clinical end-users. A key focus for MeVis's software is the image-based early detection and diagnosis of significant public health conditions, such as breast, lung, liver, and neurological disorders. Their technology supports a broad spectrum of imaging modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography. In addition to its primary software products, MeVis offers a comprehensive suite of services. This includes providing specialized software programming support to other medical technology companies, supplying skilled professionals like software developers, product and project managers, application specialists, and test engineers. The company also produces three-dimensional technical visualizations, delivers interactive online training to enhance clinicians' diagnostic proficiency, and develops internet-based applications specifically for teleradiology.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI